研究者業績

Katsutoshi Yuasa

  (湯浅 勝敏)

Profile Information

Affiliation
Faculty of PharmacyDepartment of Pharmaceutical Sciences, Musashino University
Degree
博士(薬学)

J-GLOBAL ID
201901012307552675
researchmap Member ID
B000352961

Papers

 33

Misc.

 5
  • Yuasa Katsutoshi, Hijikata Takao, Takeda Shin'ichi
    Drug Delivery System, 22(2) 140-147, 2007  
    Muscular dystrophies are progressive muscle-wasting diseases often caused by defects of genes encoding sarcolemmal or sarcolemma-associated proteins and their consequential deficiency in muscle. For the muscular dystrophies, gene therapy has been widely studied, and several strategies involving the use of viral vector-mediated delivery have been developed to restore partial expression of deficient proteins. However, systemic, specific and safe delivery of therapeutic genes to skeletal muscles remains major hurdles for the clinical application of those strategies.<BR>In this review, we first introduce genetic backgrounds and pathogenesis of muscular dystrophies and then some strategies of gene therapy, undertaken for potential treatment of muscular dystrophies. Furthermore, we describe and discuss current chemical and biological methods to carry therapeutic materials including oligonucleotides and cDNAs into individual muscle fibers and to deliver them to the musculature of the whole body.
  • 荒木 亘, 湯浅 勝敏, 武田 伸一, 城谷 圭朗, 高橋 慶吉, 田平 武
    神経化学, 38(3) 266-266, Sep, 1999  
  • 武田伸一, 湯浅勝敏
    内科, 81 354-356, 1998  
  • 湯浅勝敏,石井亜紀子,宮越友子,武田伸一
    日本臨床, 55 3148-3153, 1997  
  • 杉山政則, 湯浅勝敏, 熊谷孝則, 木下英司, 松尾裕彰, 西村基弘, 鈴木康司
    臨床病理, 43 765-771, 1995  

Presentations

 1

Research Projects

 1